Women’s Health Diagnostics Market - Development Endeavours & Business Opportunities

Komentari · 236 Pogledi

North America is the largest regional market for women's health diagnostics.

The global women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.

To know about the assumptions considered for the study download the pdf brochure @   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901

The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.

Global Women’s Health Diagnostics Market Scope:

Metrics

Details

Study Period

2020–2025

Market Size in 2025

USD 36.6 Billion 

Segment Covered

Application, End User

by Application Covered

Biopsy, Cervical Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics

By End Users Covered

Hospitals, Clinics, Home Care

Regions Covered

North America, Europe, Asia Pacific, Middle East and Africa, and South America

Key Players Profiled

Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Siemens AG (Germany), PerkinElmer, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), bioMérieux SA (France), Koninklijke Philips N.V. (Netherlands), Guided Therapeutics, Inc. (US), SuperSonic Imagine (France), FUJIFILM Holdings Corporation (Japan), DIALAB GmbH (Austria), Carestream Health, Inc. (US), MedGyn Products, Inc. (US), Cook Medical, Inc. (US), Osteometer MediTech, Inc. (Denmark), and NeuroLogica Corporation (US)

 

New product launches and acquisitions were the key strategies adopted by major companies to expand their presence in the global women’s health diagnostics market.

Hologic, Inc. holds the leading position in the women’s health diagnostics market, owing to its robust portfolio of breast imaging products and related accessories. Hologic has expanded its product portfolio through insight-driven innovation and strategic MAs to establish its position in the market.

Quest Diagnostics is the world’s leading provider of diagnostic information services and solutions. The company offers a broad portfolio of solutions in women’s health. These solutions span across areas of oncology, STDs, UTIs, HIV, pregnancy, and prenatal testing.

Click Here to Access a Free Sample Report of the Global Women’s Health Diagnostics Market @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901

Recent Developments

  • In 2021, F. Hoffmann-La Roche Ltd. Launched the uPath HER2 (4B5) Image Analysis and uPath Dual ISH Image Analysis.
  • In 2021, Hologic, Inc. acquired Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, to strengthen its presence in the women’s health diagnostics market.

Our Free Sample Report Consists of the following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 220+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis

Directly Purchase a copy of the report [270] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=128928901

Komentari